Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483041 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528
A Phase 2 study, sponsored by MedImmune.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT00483041 is a Phase 2 study that was terminated before completion, run by MedImmune. The registered enrollment target is 11 participants.
The verdict
NCT00483041, a Phase 2 study, was terminated before completion, sponsored by MedImmune.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
To evaluate the effect of MEDI-528 in adults with atopic asthma.
Interventions
- OTHER PLACEBO
- BIOLOGICAL MEDI528 9 mg/kg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483041
The ClinicalTrials.gov registry entry for NCT00483041 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PLACEBO is the first listed.
NCT00483041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483041 about?
NCT00483041 is a clinical study titled "A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528". To evaluate the effect of MEDI-528 in adults with atopic asthma.
What is the current status of trial NCT00483041?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2007-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00483041?
The interventions under investigation include: PLACEBO (OTHER), MEDI528 9 mg/kg (BIOLOGICAL).
Who is sponsoring clinical trial NCT00483041?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.